Nystatin Prescription for Infants
For oral thrush in otherwise healthy infants, prescribe nystatin oral suspension 200,000 units (2 mL) four times daily, applied with a dropper (half the dose in each side of the mouth), continuing for at least 48 hours after symptoms resolve. 1
Oral Thrush Treatment
Standard Dosing
The FDA-approved dosing for infants is straightforward 1:
- Infants: 200,000 units (2 mL) four times daily
- Premature/low birth weight infants: 100,000 units (1 mL) four times daily based on limited clinical studies
Administration Technique
- Use dropper to place half the dose in each side of the mouth
- Avoid feeding for 5-10 minutes after administration to maximize contact time
- Continue treatment for at least 48 hours after symptoms disappear and cultures confirm eradication
Important Caveat About Efficacy
While nystatin is FDA-approved and widely used, fluconazole has demonstrated superior efficacy in clinical trials. One randomized study showed clinical cure rates of only 32% with nystatin versus 100% with fluconazole in otherwise healthy infants 2. Another large multicenter trial found nystatin achieved only 21% cure by day 5 compared to 85% with miconazole 3. However, nystatin remains appropriate first-line therapy for uncomplicated oral thrush given its safety profile and topical action.
Candidal Diaper Dermatitis
Topical Application
For diaper rash with candidal involvement:
- Nystatin topical powder or cream: Apply to affected area 2-3 times daily 4
- Alternative formulations include nystatin combined with zinc oxide (100,000 IU/g nystatin + 20% zinc oxide) applied twice daily 5
Comparative Effectiveness
Research shows clotrimazole may be superior to nystatin for diaper dermatitis, with higher clinical cure rates (68% vs 47% at day 14) and better symptom reduction 5. However, nystatin remains effective with 100% microbiological cure rates and excellent safety profile.
Special Populations
Premature Neonates (<1500g)
For prophylaxis in high-risk NICU settings (not treatment of active infection):
- Oral nystatin 100,000 units three times daily for 6 weeks is an alternative to fluconazole when fluconazole is unavailable or resistance is a concern 6
- This is a weak recommendation with moderate-quality evidence, primarily for preventing invasive candidiasis in extremely premature infants 7
Critical limitation: Nystatin prophylaxis cannot be administered during ileus, gastrointestinal disease, feeding intolerance, or hemodynamic instability—common situations in premature infants that limit its applicability 6
Safety Considerations
Nystatin is generally well-tolerated with minimal systemic absorption:
- Most common adverse effects: poor taste and gastrointestinal reactions 8
- Not for systemic mycoses—topical action only 1
- Safe in pregnancy (category not established, but no known fetal harm) 1
- Caution in nursing mothers (excretion in breast milk unknown) 1
Treatment Duration
- Oral thrush: Minimum 48 hours after clinical resolution and negative cultures 1
- Diaper dermatitis: Typically 7-14 days until complete healing 5
- Prophylaxis in premature neonates: 6 weeks 6
When to Consider Alternatives
Switch from nystatin to systemic therapy (fluconazole) if:
- No improvement after 5-7 days of treatment
- Severe or extensive disease
- Immunocompromised patient
- Recurrent infections despite adequate nystatin therapy
The evidence consistently shows fluconazole achieves faster cure rates and higher efficacy than nystatin for oral thrush 2, 3, 8, though nystatin remains appropriate initial therapy for uncomplicated cases given its safety and topical mechanism.